| Human papillomavirus and survival of patients with oropharyngeal cancer KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ... New England Journal of Medicine 363 (1), 24-35, 2010 | 4925 | 2010 |
| Evidence for a causal association between human papillomavirus and a subset of head and neck cancers ML Gillison, WM Koch, RB Capone, M Spafford, WH Westra, L Wu, ... Journal of the National Cancer Institute 92 (9), 709-720, 2000 | 3276 | 2000 |
| Case–control study of human papillomavirus and oropharyngeal cancer G D'Souza, AR Kreimer, R Viscidi, M Pawlita, C Fakhry, WM Koch, ... New England Journal of Medicine 356 (19), 1944-1956, 2007 | 2921 | 2007 |
| Improved survival of patients with human papillomavirus–positive head and neck squamous cell carcinoma in a prospective clinical trial C Fakhry, WH Westra, S Li, A Cmelak, JA Ridge, H Pinto, A Forastiere, ... Journal of the National Cancer Institute 100 (4), 261-269, 2008 | 2543 | 2008 |
| HPV-associated head and neck cancer: a virus-related cancer epidemic S Marur, G D'Souza, WH Westra, AA Forastiere The lancet oncology 11 (8), 781-789, 2010 | 1657 | 2010 |
| Genetic progression model for head and neck cancer: implications for field cancerization J Califano, P Van Der Riet, W Westra, H Nawroz, G Clayman, ... Cancer research 56 (11), 2488-2492, 1996 | 1616 | 1996 |
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 N Agrawal, MJ Frederick, CR Pickering, C Bettegowda, K Chang, RJ Li, ... Science 333 (6046), 1154-1157, 2011 | 1605 | 2011 |
| Distinct risk factor profiles for human papillomavirus type 16–positive and human papillomavirus type 16–negative head and neck cancers ML Gillison, G D'Souza, W Westra, E Sugar, W Xiao, S Begum, R Viscidi Journal of the National Cancer Institute 100 (6), 407-420, 2008 | 1589 | 2008 |
| BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer M Xing, WH Westra, RP Tufano, Y Cohen, E Rosenbaum, KJ Rhoden, ... The Journal of Clinical Endocrinology & Metabolism 90 (12), 6373-6379, 2005 | 1024 | 2005 |
| BRAF mutation in papillary thyroid carcinoma Y Cohen, M Xing, E Mambo, Z Guo, G Wu, B Trink, U Beller, WH Westra, ... Journal of the National Cancer Institute 95 (8), 625-627, 2003 | 999 | 2003 |
| High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma AL Reed, J Califano, P Cairns, WH Westra, RM Jones, W Koch, S Ahrendt, ... Cancer research 56 (16), 3630-3633, 1996 | 770 | 1996 |
| Frequency of homozygous deletion at p16/CDKN2 in primary human tumours P Cairns, TJ Polascik, Y Eby, K Tokino, J Califano, A Merlo, L Mao, ... Nature genetics 11 (2), 210-212, 1995 | 767 | 1995 |
| World Health Organization classifications tumours. Pathology and genetics of head and neck tumours L Barnes, JW Eveson, P Reichart, D Sidransky Lyon: IARC, 2005 | 765 | 2005 |
| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei, B Bendlova, L Yip, ... Jama 309 (14), 1493-1501, 2013 | 748 | 2013 |
| TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck ML Poeta, J Manola, MA Goldwasser, A Forastiere, N Benoit, JA Califano, ... New England journal of medicine 357 (25), 2552-2561, 2007 | 671 | 2007 |
| Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung M Sanchez-Cespedes, P Parrella, M Esteller, S Nomoto, B Trink, ... Cancer research 62 (13), 3659-3662, 2002 | 607 | 2002 |
| AIS is an oncogene amplified in squamous cell carcinoma K Hibi, B Trink, M Patturajan, WH Westra, OL Caballero, DE Hill, ... Proceedings of the National Academy of Sciences 97 (10), 5462-5467, 2000 | 605 | 2000 |
| Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma S Lyford-Pike, S Peng, GD Young, JM Taube, WH Westra, B Akpeng, ... Cancer research 73 (6), 1733-1741, 2013 | 600 | 2013 |
| Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma S Begum, D Cao, M Gillison, M Zahurak, WH Westra Clinical Cancer Research 11 (16), 5694-5699, 2005 | 458* | 2005 |
| Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients SLB Rosas, W Koch, MG da Costa Carvalho, L Wu, J Califano, W Westra, ... Cancer research 61 (3), 939-942, 2001 | 455 | 2001 |
